Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group (Q44227096)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group |
scientific article |
Statements
1 reference
Phase II study of marimastat (BB-2516) in malignant melanoma: a clinical and tumor biopsy study of the National Cancer Institute of Canada Clinical Trials Group (English)
1 reference
National Cancer Institute of Canada Clinical Trials Group
1 reference
Ian Quirt
1 reference
Audley Bodurth
1 reference
Reinhard Lohmann
1 reference
James Rusthoven
1 reference
Karl Belanger
1 reference
Vincent Young
1 reference
Nancy Wainman
1 reference
William Stewar
1 reference
Elizabeth Eisenhauer
1 reference
1 November 2002
1 reference
1 reference
20
1 reference
4
1 reference
431-437
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference